Trial intelligence / Profile preview

Hyaluronic acid topical gel for recurrent aphthous stomatitis

ISRCTN16509838Phase 3Completed

Sponsor
University of Milan
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in aphthosis (RAS) comparing Bexident Aftas Gel with Placebo gel (2 arms). Primary endpoint: Ulcer pain by visual analogue scale. Started Oct 2018; status: completed.

02

Drugs

Bexident Aftas Gel
03

Conditions

aphthosis (RAS)

Beyond the preview

Go deeper on ISRCTN16509838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN16509838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call